Xylocaine and Depo-medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xylocaine (lidocaine hydrochloride) and Depo-medrol (methylprednisolone acetate). Common drug interactions include injury among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Xylocaine and Depo-medrol. It is created by eHealthMe based on reports of 95 people who take the same drugs from the FDA, and is updated regularly.

What is Xylocaine?

Xylocaine has active ingredients of lidocaine hydrochloride. eHealthMe is studying from 5,716 Xylocaine users. Check the latest studies of Xylocaine.

What is Depo-medrol?

Depo-medrol has active ingredients of methylprednisolone acetate. It is often used in birth control. eHealthMe is studying from 5,933 Depo-medrol users. Check the latest studies of Depo-medrol.



On Jul, 19, 2026

95 people who take Xylocaine and Depo-medrol together, and have interactions are studied.

Xylocaine and Depo-medrol drug interactions.

What are the common drug interactions of Xylocaine and Depo-Medrol, by gender? *:

female:

  1. Injury
  2. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  3. Gait disturbance
  4. Bacterial infection
  5. Burning sensation
  6. Hypersensitivity
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Muscle spasms (muscle contraction)
  9. Skin discolouration (change of skin colour)
  10. Vomiting

male:

  1. Pain
  2. Arthralgia (joint pain)
  3. Nausea (feeling of having an urge to vomit)
  4. Streptococcal infection
  5. Abdominal hernia
  6. Asthenia (weakness)
  7. Back pain
  8. Blood glucose increased
  9. Chest pain
  10. Chondrolysis (a condition that occurs when there is sudden, severe damage to joint cartilage)

What are the common drug interactions of Xylocaine and Depo-Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Dry skin
  3. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  4. Osteomyelitis (infection of bone)
  5. Pain
  6. Rash erythematous (redness of the skin)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Rash pruritic (redness with itching)
  9. Skin atrophy (wasting of skin)

30-39:

  1. Dysarthria (speech disorder)
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Nausea (feeling of having an urge to vomit)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Visual disturbance
  9. Weakness

40-49:

  1. Pain
  2. Vomiting
  3. Weight increased
  4. Ear disorder
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Gingival bleeding (bleeding gums)
  7. Impaired healing
  8. Injection site pain
  9. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  10. Myopathy steroid (a muscular disease in which the muscle fibres do not function due to steroid)

50-59:

  1. Constipation
  2. Gastric ulcer (stomach ulcer)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Injury
  5. Intestinal obstruction
  6. Irritable bowel syndrome
  7. Melanosis coli (a condition that can be caused from chronic laxative abuse)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)
  10. Fall

60+:

  1. Muscular weakness (muscle weakness)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Anxiety
  4. General physical health deterioration (weak health status)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Burning sensation
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Muscle twitching
  9. Sensory loss (senses loss)
  10. Bacterial infection

What are the existing conditions these people have? *

  1. Pain: 21 people, 22.11%
  2. Joint Pain: 17 people, 17.89%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 8.42%
  4. Back Pain: 7 people, 7.37%
  5. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 6 people, 6.32%
  6. Nerve Block (the interruption of signals travelling along a nerve): 5 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Xylocaine and Depo-medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xylocaine and Depo-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xylocaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Depo-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xylocaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depo-medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine hydrochloride and methylprednisolone acetate (the active ingredients of Xylocaine and Depo-medrol, respectively), and Xylocaine and Depo-medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: